Individualization of growth hormone therapy

Area of Science:

• Pediatrics
• Endocrinology
• Genetics

Background:

• Small for gestational age (SGA) births affect a significant portion of children with short stature.
• SGA children require thorough assessment for underlying conditions and neurodevelopmental issues.
• Growth hormone (GH) therapy is a key treatment for short stature in SGA children.

Purpose of the Study:

• To highlight the importance of individualized treatment for short stature in SGA children.
• To discuss the role of prediction models in optimizing GH therapy.
• To identify factors influencing treatment response in SGA children.

Main Methods:

• Review of randomized controlled trials (RCTs) on GH therapy in SGA children.
• Analysis of prediction models for GH therapy outcomes.
• Identification of modifiable and non-modifiable factors affecting treatment.

Main Results:

• GH therapy demonstrates significant growth acceleration in childhood and improved adult height in SGA children.
• Prediction models enable personalized GH dosing and treatment initiation timing.
• Factors like target height, weight SDS, and initial treatment response influence outcomes.

Conclusions:

• Individualized GH therapy, informed by prediction models, is crucial for optimizing height outcomes in SGA children.
• Understanding modifiable and non-modifiable factors allows for tailored treatment strategies.
• Early intervention and personalized approaches are key to addressing short stature in SGA populations.